Xia D, Wang Q, Bai W, Wang E, et al. Optimal time point of response assessment for predicting survival is associated with tumor burden in hepatocellular carcinoma receiving repeated transarterial chemoembolization. Eur Radiol 2022 Apr 6. pii: 10.1007/s00330-022-08716.
PMID: 35381853